Regeneron Pharmaceuticals, Inc.REGN

Where REGN's EPS (TTM) sits inside its own 10-year distribution, with the yearly high, low and average.

$827.72-15.75 (-1.87%)Previous close
NASDAQHealthcare

REGN EPS (TTM): current value, 10-year range and year-by-year history

+20.2%/yr10Y CAGR

REGN's earnings per share compounded at 20.2%/year over the last 10 years — strong long-term growth.

EPS (TTM) History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
REGN EPS (TTM) historyREGN EPS (TTM) from Sep 2023 to Jun 2026: low 33.85, high 41.76, latest 40.43.33.2235.5137.840.142.39Sep 23Mar 24Sep 24Jun 25Dec 25Jun 26med 39.28

REGN EPS (TTM) by year

Yearly range of REGN’s eps (ttm) from 2016 to 2026. Over the full period it ranged from $6.89 to $72.08, averaging $31.70.

REGN EPS (TTM) — yearly low, average, high and year-end values
YearLowAverageHighYear-end
2026$40.43$40.74$41.04$40.43
2025$39.28$40.57$41.76$41.56
2024$33.85$37.57$40.41$38.28
2023$34.75$36.11$37.83$34.75
2022$38.24$51.59$70.60$38.24
2021$35.33$56.43$72.08$72.08
2020$19.90$25.94$30.67$30.67
2019$17.99$19.07$21.13$18.46
2018$12.31$15.76$21.30$21.30
2017$8.31$9.90$11.01$10.31
2016$6.89$7.32$7.74$7.74

Net income divided by diluted shares outstanding, over the trailing twelve months. Watching EPS trend over time reveals whether earnings are growing, stagnant, or deteriorating — and provides the denominator behind P/E.

FormulaNet Income ÷ Diluted Shares Outstanding
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.